Preliminary observations of the phase 1 study, conducted in Cyprus, as announced by the Biobank Centre of Excellence and Biomedical Research biobank.cy of the University of Cyprus, show that antibody levels after vaccination against SARS-CoV-2 with first and second dose, rise much higher compared to those of people who became ill, while again the levels drop in a few months after the second dose.
This research is ongoing and the invitation is open to vaccinated volunteers to monitor their antibodies over time.
(CNA)
CNA
Contents of this article including associated images are owned by CNA
Views & opinions expressed are those of the author and/or CNA
Source
